HRS4R
Vull donar
Firma
RAFEL MARCOS-GRAGERA
Posició
Cap de Grup - R4
Caps de Grup - R4

Publicacions

Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X

Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.

EUROPEAN RADIOLOGY, 2022, 32, 621-629 dx.doi.org/10.1007/s00330-021-08118-y

Sanvisens A, Ameijide A, Carulla M, Marcos-Gragera R

Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN).

MEDICINA CLINICA, 2022, 158, 284-290 dx.doi.org/10.1016/j.medcli.2021.09.035

Solans M, Sanvisens A, Ameijide A, Merino S, Rojas D, Alemán A, Banqueri E, Chico M, Marcos AI, de Castro V, Gil L, de Munain AL, Puigdemont M, Sánchez MJ, Perucha J, Ruiz-Armengol P, Chirlaque MD, Guevara M, Carulla M, Marcos-Gragera R

Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.

SCIENTIFIC REPORTS, 2022, 12, 323-323 dx.doi.org/10.1038/s41598-021-03734-6

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe.

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780

Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D

Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study).

CANCER CAUSES & CONTROL, 2022, 33, 125-136 dx.doi.org/10.1007/s10552-021-01511-4
0

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19063605
0

Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain.

BMC MED RES METHODOL, 2022, 22, 95-95 dx.doi.org/10.1186/s12874-022-01582-0

Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, Urban A, Palhua RL, Martín-Romero F, Ortiz-Duran MR, Marcos-Gragera R

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19084802
0

Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred.

SCIENTIFIC REPORTS, 2022, 12, 8097-8097 dx.doi.org/10.1038/s41598-022-12228-y
0

Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7, 711-723 dx.doi.org/10.1016/S2468-1253(22)00084-X

Formulari de contacte

Coneix l’IDIBGI!

menu